These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 6533062)

  • 1. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities.
    Eisenbrand G
    IARC Sci Publ; 1984; (57):695-708. PubMed ID: 6533062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage and repair in the bone marrow of rats treated with four chloroethylnitrosoureas.
    Bedford P; Eisenbrand G
    Cancer Res; 1984 Feb; 44(2):514-8. PubMed ID: 6229329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
    Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
    Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug design: nitrosoureas.
    Eisenbrand G; Müller N; Schreiber J; Stahl W; Sterzel W; Berger MR; Zeller WJ; Fiebig H
    IARC Sci Publ; 1986; (78):281-94. PubMed ID: 3583393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method to determine the carbamoylating potential of 1-(2-chloroethyl)-1-nitrosoureas.
    Stahl W; Krauth-Siegel RL; Schirmer RH; Eisenbrand G
    IARC Sci Publ; 1987; (84):191-3. PubMed ID: 2960614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cell cycle position on the survival of 9L cells treated with nitrosoureas that alkylate, cross-link, and carbamoylate.
    Linfoot PA; Gray JW; Dean PN; Marton LJ; Deen DF
    Cancer Res; 1986 May; 46(5):2402-6. PubMed ID: 3697983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of more selective anti-cancer nitrosoureas.
    Eisenbrand G; Berger MR; Fischer J; Schneider MR; Tang W; Zeller WJ
    Anticancer Drug Des; 1988 Mar; 2(4):351-9. PubMed ID: 3365304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological activity of hydroxylated chloroethylnitrosoureas.
    Zeller WJ; Frühauf S; Chen G; Eisenbrand G; Lijinsky W
    Cancer Res; 1989 Jun; 49(12):3267-70. PubMed ID: 2720679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapeutic characterization of new nitrosourea compounds].
    Zeller WJ; Berger MR; Eisenbrand G; Petru E
    Arch Geschwulstforsch; 1988; 58(3):137-49. PubMed ID: 3415433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of 1-(2-chloroethyl)-1-nitrosourea activity at the cellular level.
    Weinkam RJ; Dolan ME
    J Med Chem; 1983 Nov; 26(11):1656-9. PubMed ID: 6226795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic toxicity and carcinogenicity of cytostatic N-nitroso-(2-chloroethyl) ureas after repeated intravenous application to rats.
    Eisenbrand G; Habs M
    Dev Toxicol Environ Sci; 1980; 8():273-8. PubMed ID: 7308028
    [No Abstract]   [Full Text] [Related]  

  • 12. The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas.
    Bedford P; Berger MR; Eisenbrand G; Schmähl D
    J Cancer Res Clin Oncol; 1984; 108(1):141-7. PubMed ID: 6235230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037; CCNU)--clinical brochure.
    Carter SK; Newman JW
    Cancer Chemother Rep 3; 1968 Dec; 1(1):115-51. PubMed ID: 4917773
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of rat liver DNA polymerase by nitrosoureas and isocyanates.
    Baril BB; Baril EF; Laszlo J; Wheeler GP
    Cancer Res; 1975 Jan; 35(1):1-5. PubMed ID: 162855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 1-(2-hydroxyethyl)-1-nitrosourea and comparison of its carcinogenicity with that of 1-ethyl-1-nitrosourea.
    Swenson DH; Frei JV; Lawley PD
    J Natl Cancer Inst; 1979 Dec; 63(6):1469-73. PubMed ID: 292815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reaction of N-(2-chloroethyl)-N-nitrosoureas with DNA: effect of buffers on DNA adduction, cross-linking, and cytotoxicity.
    Chen FX; Bodell WJ; Liang G; Gold B
    Chem Res Toxicol; 1996; 9(1):208-14. PubMed ID: 8924592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerobic and hypoxic toxicity of a new class of mixed-function drugs associating nitroimidazoles and chloroethylnitrosourea in nitrosourea-sensitive (Mer-) and -resistant (Mer+) human tumor cells.
    Mulcahy RT; Carminati A; Barascut JL; Imbach JL
    Cancer Res; 1988 Feb; 48(4):798-801. PubMed ID: 3338077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of newly synthesized 2-chloroethylnitrosoureas in preterminal leukemia L 5222 and in two transplanted neurogenic tumors.
    Berger M; Zeller WJ; Eisenbrand G; Lin PZ; Nakra M; Schmähl D
    Arzneimittelforschung; 1982; 32(5):481-4. PubMed ID: 6285938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of nicotine with anticancer treatment.
    Berger MR; Zeller WJ
    Klin Wochenschr; 1988; 66 Suppl 11():127-33. PubMed ID: 3184771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dependence of the antitumor activity of nitroso alkyl urea derivatives on their chemical structure].
    Sharashidze LK; Turkiia NG; Lagidze DR; Adamiia IK; Asatiani VV
    Eksp Onkol; 1989; 11(2):62-5. PubMed ID: 2737133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.